Financial Ratios

DYNACHEM PHARMA EXPORTS LTD.

NSE : NABSE : 524562ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Mar2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)0.000.000.000.000.01
   CEPS(Rs)0.000.000.000.000.01
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)9.199.1910.0010.009.19
   Tax Rate(%)0.000.000.000.0016.84
Margin Ratios
   Core EBITDA Margin(%)11.59
   EBIT Margin(%)11.59
   Pre Tax Margin(%)11.57
   PAT Margin (%)9.63
   Cash Profit Margin (%)9.63
Performance Ratios
   ROA(%)0.010.010.000.000.11
   ROE(%)0.010.010.000.000.12
   ROCE(%)0.010.010.000.000.14
   Asset Turnover(x)0.000.000.000.000.01
   Sales/Fixed Asset(x)0.000.000.000.000.05
   Working Capital/Sales(x)0.000.000.000.000.13
Efficiency Ratios
   Fixed Capital/Sales(x)20.80
   Receivable days0.00
   Inventory Days0.00
   Payable days7.68
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)89.71
   EV/Core EBITDA(x)0.000.000.000.00773.84
   EV/EBIT(x)0.000.000.000.00773.84
   EV/CE(x)1.091.091.001.001.02
   M Cap / Sales0.00
Growth Ratio
   Net Sales Growth(%)-100.000.00
   Core EBITDA Growth(%)-35.46210.13-31.75-96.520.00
   EBIT Growth(%)-35.46210.13-31.75-96.520.00
   PAT Growth(%)-35.46244.75-25.54-96.550.00
   EPS Growth(%)-35.46244.75-25.54-96.550.00
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)395.85395.58597.79372.54250.81
   Quick Ratio(x)395.85395.58597.79372.54250.81
   Interest Cover(x)9.965.70649.47
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.